Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.51 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | CES1 | P23141 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | FABP3 | P05413 | 5/20 | 0.47 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.44 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL466646 | 1.00 | FAAH (0.51) | FAAHSOAT1MEN1TP53CYP1A2 | |
| SCHEMBL466851 | 1.00 | FAAH (0.51) | FAAHSOAT1MEN1TP53CYP1A2 | |
| SCHEMBL466745 | 0.96 | KDM4E (0.55) | FAAHSOAT1MEN1TP53CYP1A2 | |
| SCHEMBL466582 | 0.92 | SMPD1 (0.44) | FAAHMEN1CYP1A2KMT2ACES1 | |
| SCHEMBL466941 | 0.92 | SMPD1 (0.44) | FAAHMEN1CYP1A2KMT2ACES1 | |
| SCHEMBL466673 | 0.92 | SMPD1 (0.44) | FAAHMEN1CYP1A2KMT2ACES1 | |
| SCHEMBL466752 | 0.92 | SMPD1 (0.44) | FAAHMEN1CYP1A2KMT2ACES1 | |
| SCHEMBL466809 | 0.91 | FDPS (0.42) | FAAHMEN1CYP1A2KMT2ACES1 | |
| SCHEMBL1394914 | 0.78 | FAAH (0.58) | FAAHSOAT1MEN1TP53CYP1A2 | |
| SCHEMBL637887 | 0.78 | FAAH (0.58) | FAAHSOAT1MEN1TP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2860255-A1 | Compositions comprising cationic and neutral lipids for transfecting nucleic acid molecules into eukaryotic cells | Technische Universität Graz (AT) | 2015-04-15 | — | — | EP | claimed |
| CN-117338917-A | Influenza vaccine | 斯微(上海)生物科技股份有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-117286156-A | Rabies virus mRNA vaccine | 斯微(上海)生物科技股份有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-117187266-A | mRNA rabies vaccine for animals | 斯微(上海)生物科技股份有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-115813848-B | Reagent, method and application of micro-needle injection mRNA encoding bispecific antibody drug | 上海臻上医药科技有限公司 | 2023-08-08 | — | — | CN | disclosed |
| CN-115429741-B | Microneedle injection mRNA vaccine and application thereof | 上海臻上医药科技有限公司 | 2023-06-16 | — | — | CN | disclosed |
| CN-115698295-B | Vaccine reagent and inoculation method | 斯微(上海)生物科技股份有限公司 | 2023-05-16 | — | — | CN | disclosed |
| US-20200197306-A1 | CATIONIC LIQUID CRYSTALLINE NANOPARTICLES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-06-25 | — | — | US | disclosed |
| EP-2876159-B1 | MOLECULAR ENGINEERING METHOD FOR IN VITRO EVOLUTION OF MEMBRANE PROTEIN | JAPAN SCIENCE & TECH AGENCY (JP) | 2019-08-07 | — | — | EP | disclosed |
| US-9862942-B2 | In vitro membrane protein molecular evolutionary engineering technique | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2018-01-09 | — | — | US | disclosed |
| EP-2405001-A1 | NUCLEIC ACID COMPLEX AND NUCLEIC ACID-DELIVERING COMPOSITION | Takeuchi, Hirofumi (JP) | 2012-01-11 | — | — | EP | disclosed |
| US-8030075-B2 | Carrier composition for nucleic acid transport | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2011-10-04 | — | — | US | disclosed |
| EP-2217208-B1 | NUCLEIC ACID COMPLEX AND NUCLEIC ACID DELIVERY COMPOSITION | OTSUKA PHARMA CO LTD (JP) | 2011-08-31 | — | — | EP | disclosed |
| US-20100305190-A1 | NUCLEIC ACID COMPLEX AND NUCLEIC ACID DELIVERY COMPOSITION | Takeuchi, Hirofumi (JP) | 2010-12-02 | — | — | US | disclosed |
| EP-2217208-A2 | NUCLEIC ACID COMPLEX AND NUCLEIC ACID DELIVERY COMPOSITION | Otsuka Pharmaceutical Co., Ltd. (JP) | 2010-08-18 | — | — | EP | disclosed |
| US-20100063131-A1 | PROMPT NUCLEIC ACID DELIVERY CARRIER COMPOSITION | Takeuchi, Hirofumi (JP) | 2010-03-11 | — | — | US | disclosed |
| EP-2140870-A1 | PROMPT NUCLEIC ACID DELIVERY CARRIER COMPOSITION | Otsuka Pharmaceutical Co., Ltd. (JP) | 2010-01-06 | — | — | EP | disclosed |
| US-20090258923-A1 | Carrier Composition for Nucleic Acid Transport | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2009-10-15 | — | — | US | disclosed |
| WO-2009061003-A2 | NUCLEIC ACID COMPLEX AND NUCLEIC ACID DELIVERY COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2009-05-14 | — | — | WO | disclosed |
| EP-1946761-A1 | CARRIER COMPOSITION FOR NUCLEIC ACID TRANSPORT | Otsuka Pharmaceutical Co., Ltd. (JP) | 2008-07-23 | — | — | EP | disclosed |